Speaking of Cancer Research

Notable quotes from this year’s annual meeting of the American Association for Cancer Research

By | April 5, 2017

JEF AKST

“This is no time to undercut progress, for God’s sake. It’s no time to let up. It’s time to double down. It’s time we deliver on the promise of science and technology to extend and improve lives.”

—Former US Vice President Joe Biden

 

“Funding for cancer research isn’t something you can turn on and off like a faucet.”

Nancy Davidson, AACR President

 

“There has been a revolution in cancer research in the past decade. If I were to summarize that revolution in one sentence it would be: cancer results from the sequential accumulation of genomic alterations. . . . The challenge for all of us here to today is to achieve the next revolution, and that is to dramatically reduce deaths from cancer.”

Bert Vogelstein, Johns Hopkins Medicine

 

“At first blush, the problem of [cancer drug] resistance seems insurmountable. It’s multifactorial and heterogeneous. There can be multiple resistance mechanisms operating in a particular patient.”

Levi Garraway, Eli Lilly

 

“Early detection doesn’t have to be very early. . . . It takes years, perhaps decades, for a [malignancy] to evolve into a widely metastatic lesion, offering a huge window of opportunity to detect those cancers and intervene in the process.”

Vogelstein

 

“In our fight against cancer, we have to be unwilling to postpone for even a second. . . . Let’s keep it going, folks. This is no time to stop the momentum.”

Biden

Add a Comment

Avatar of: You

You

Processing...
Processing...

Sign In with your LabX Media Group Passport to leave a comment

Not a member? Register Now!

LabX Media Group Passport Logo

Comments

Avatar of: JonRichfield

JonRichfield

Posts: 115

April 8, 2017

Nancy Davidson's remark:“Funding for cancer research isn’t something you can turn

on and off like a faucet” is of course quite correct, but the

word "cancer" is redundant in context.

 

Popular Now

  1. Opinion: Why I Published in a Predatory Journal
    News & Opinion Opinion: Why I Published in a Predatory Journal

    My “colleagues” and I at the fictitious Arthur Vandelay Urological Research Institute were surprised to find our bogus “uromycitisis” case report swiftly accepted, with only minor revisions requested.

  2. Consilience, Episode 3: Cancer, Obscured
  3. March for Science: Dispatches from Washington, DC
  4. Record-Setting Corn Grows 45 Feet Tall
AAAS